Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 01 11 2020
revised: 04 01 2021
accepted: 04 01 2021
pubmed: 15 1 2021
medline: 23 4 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Administrative claims data are prone to underestimate the burden of non-tuberculous mycobacterial pulmonary disease (NTM-PD). We developed machine learning-based algorithms using historical claims data from cases with NTM-PD to predict patients with a high probability of having previously undiagnosed NTM-PD and to assess actual prevalence and incidence. Adults with incident NTM-PD were classified from a representative 5% sample of the German population covered by statutory health insurance during 2011-2016 by the International Classification of Diseases, 10th revision code A31.0. Pre-diagnosis characteristics (patient demographics, comorbidities, diagnostic and therapeutic procedures, and medications) were extracted and compared to that of a control group without NTM-PD to identify risk factors. Applying a random forest model (area under the curve 0.847; total error 19.4%) and a risk threshold of >99%, prevalence and incidence rates in 2016 increased 5-fold and 9-fold to 19 and 15 cases/100,000 population, respectively, for both coded and non-coded vs. coded cases alone. The use of a machine learning-based algorithm applied to German statutory health insurance claims data predicted a considerable number of previously unreported NTM-PD cases with high probabilty.

Identifiants

pubmed: 33444748
pii: S1201-9712(21)00006-0
doi: 10.1016/j.ijid.2021.01.003
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-406

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Felix C Ringshausen (FC)

Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany; German Center for Lung Research (DZL), Giessen, Germany. Electronic address: Ringshausen.Felix@mh-hannover.de.

Raphael Ewen (R)

Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany.

Jan Multmeier (J)

Elsevier Health Analytics, Berlin, Germany.

Bondo Monga (B)

Elsevier Health Analytics, Berlin, Germany; University of Lubumbashi, Lubumbashi, DR Congo.

Marko Obradovic (M)

Insmed Germany GmbH, Frankfurt am Main, Germany.

Roald van der Laan (R)

Insmed Netherlands BV, Utrecht, Netherlands.

Roland Diel (R)

German Center for Lung Research (DZL), Giessen, Germany; Institute for Epidemiology, University Medical Center Schleswig-Holstein, Kiel, Germany; LungenClinic Grosshansdorf, Grosshansdorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH